Literature DB >> 12690582

A randomized clinical trial of a wellness intervention for women with multiple sclerosis.

Alexa K Stuifbergen1, Heather Becker, Shelley Blozis, Gayle Timmerman, Vicki Kullberg.   

Abstract

OBJECTIVE: To examine the effects of a wellness intervention program for women with multiple sclerosis (MS) on health behaviors and quality of life (QOL).
DESIGN: Randomized clinical trial.
SETTING: Community setting in the southwestern United States. PARTICIPANTS: Convenience sample of 113 women with physician-confirmed MS (mean age, 45.79y).
INTERVENTIONS: The 2-phase intervention program included lifestyle-change classes for 8 weeks, then telephone follow-up for 3 months. Participants were followed over an 8-month period. MAIN OUTCOME MEASURES: A series of self-report instruments to measure barriers, resources, self-efficacy for health behaviors, health promotion behaviors, and health-related QOL were completed at baseline, 2 months (after the classes), 5 months (after telephone follow-up), and at 8 months. Principal outcomes measures were health-promoting behaviors (scores on the Health Promoting Lifestyle Profile II) and QOL (scores on the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36] scales).
RESULTS: Hierarchical linear modeling techniques revealed a statistically significant group by time effect for self-efficacy for health behaviors, health-promoting behaviors, and the mental health and pain scales of the SF-36.
CONCLUSION: These data provide initial support for the positive effects of wellness interventions to improve health behaviors and selected dimensions of QOL for women with MS.

Entities:  

Mesh:

Year:  2003        PMID: 12690582     DOI: 10.1053/apmr.2003.50028

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  48 in total

1.  A randomized controlled trial of a cognitive rehabilitation intervention for persons with multiple sclerosis.

Authors:  Alexa K Stuifbergen; Heather Becker; Frank Perez; Janet Morison; Vicki Kullberg; Ana Todd
Journal:  Clin Rehabil       Date:  2012-02-02       Impact factor: 3.477

2.  Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.

Authors:  Heather Becker; Alexa Stuifbergen; Hwayoung Lee; Vicki Kullberg
Journal:  Int J MS Care       Date:  2014

3.  Depression in multiple sclerosis: a longitudinal analysis.

Authors:  Claudia C Beal; Alexa K Stuifbergen; Adama Brown
Journal:  Arch Psychiatr Nurs       Date:  2007-08       Impact factor: 2.218

4.  Clinician's Commentary on Ploughman et al.(1).

Authors:  Jo-Anne Howe
Journal:  Physiother Can       Date:  2012-01-31       Impact factor: 1.037

5.  Predictors of quality of life for long-term cancer survivors with preexisting disabling conditions.

Authors:  Heather Becker; Sook Jung Kang; Alexa Stuifbergen
Journal:  Oncol Nurs Forum       Date:  2012-03       Impact factor: 2.172

6.  Self-efficacy as a predictor of self-reported physical, cognitive, and social functioning in multiple sclerosis.

Authors:  Margaret M Schmitt; Yael Goverover; John Deluca; Nancy Chiaravalloti
Journal:  Rehabil Psychol       Date:  2013-12-09

7.  A telehealth intervention to promote healthy lifestyles after stroke: The Stroke Coach protocol.

Authors:  Brodie M Sakakibara; Scott A Lear; Susan I Barr; Oscar Benavente; Charlie H Goldsmith; Noah D Silverberg; Jennifer Yao; Janice J Eng
Journal:  Int J Stroke       Date:  2017-09-04       Impact factor: 5.266

8.  Using an e-health intervention to promote the health of cancer survivors with preexisting disabling conditions.

Authors:  Heather Becker; Mike Mackert; Sook Jung Kang
Journal:  Comput Inform Nurs       Date:  2013-03       Impact factor: 1.985

9.  Longitudinal predictors of attitudes toward aging among women with multiple sclerosis.

Authors:  Tracie Harrison; Shelley Blozis; Alexa Stuifbergen
Journal:  Psychol Aging       Date:  2008-12

10.  The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia.

Authors:  Lorraine J Phillips; Alexa K Stuifbergen
Journal:  Int J Rehabil Res       Date:  2010-06       Impact factor: 1.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.